Kurilensoside F

(3S,4S,5S,8S,9R,10R,13R,14S,15R,16R,17R)-3-[(2S,3S,5R)-4,5-dihydroxy-3-methoxyoxan-2-yl]oxy-17-[(2R,6S)-7-hydroxy-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,6,7,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-4,5,8,15,16-pentol

SFKLBZDYZMNXCK-OHVRGURYSA-N CHEBI:185981 0 Reactome links 4 studies
4 Observed studies
4 Observed diff profiles
0 Reactome pathways

Metabolite details

Identifier
SFKLBZDYZMNXCK-OHVRGURYSA-N
IUPAC name
(3S,4S,5S,8S,9R,10R,13R,14S,15R,16R,17R)-3-[(2S,3S,5R)-4,5-dihydroxy-3-methoxyoxan-2-yl]oxy-17-[(2R,6S)-7-hydroxy-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,6,7,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-4,5,8,15,16-pentol
Preferred name
Kurilensoside F
INN name
Synonym
ChEBI
CHEBI:185981

Reactome pathways

  • No Reactome pathways listed for this metabolite.

Observed in studies

Observed in differential profiles